论文信息 - Phase II, Multicenter, Single‐arm Trial of Eribulin as First‐line Therapy for Patients With Aggressive Taxane‐pretreated HER2‐Negative Metastatic Breast Cancer: The MERIBEL Study - 字舞流文

Phase II, Multicenter, Single‐arm Trial of Eribulin as First‐line Therapy for Patients With Aggressive Taxane‐pretreated HER2‐Negative Metastatic Breast Cancer: The MERIBEL Study

M. Martínez-García | A. Llombart-Cussac | L. Calvo | A. Antón | J. Cortés | P. Zamora | V. Ortega | N. Afonso | J. Illarramendi | Y. Fernández | E. Blanco | I. Garau | E. Aguirre | C. R. Rodríguez Sánchez | J. Peréz-García | M. Sampayo | Mirta García